Natriuretic peptides and the Framingham Risk score for screening of asymptomatic left ventricular systolic dysfunction in high-risk patients in primary care. The DAVID-BERG study

Autor:	Mauro Gori, Maria Rosaria Rutili, Alessandra Fontana, Michele Senni, Paola Ferrari, Antonello Gavazzi, Marina Parolini, Silvia Guideri, Luigi Donzelli, Attilio Iacovoni, A. Filippi, Renata De Maria, Aurelia Grosu
Přispěvatelé:	Iacovoni, A, Demaria, R, Gavazzi, A, Grosu, A, Fontana, A, Guideri, S, Gori, M, Ferrari, P, Filippi, A, Rutili, M, Donzelli, L, Parolini, M, Senni, M
Rok vydání:	2013
Předmět:	Male medicine.medical_specialty medicine.drug_class Asymptomatic left ventricular systolic dysfunction Heart failure Primary care Asymptomatic Cohort Studies Ventricular Dysfunction Left Risk Factors Internal medicine medicine Natriuretic peptide Humans Prospective Studies Natriuretic Peptides Aged High risk patients Framingham Risk Score Primary Health Care business.industry Middle Aged Cardiovascular risk medicine.disease Asymptomatic Diseases Screening Cardiology Female medicine.symptom Cardiology and Cardiovascular Medicine business Biomarkers
Zdroj:	International Journal of Cardiology. 168:5093-5095
ISSN:	0167-5273
DOI:	10.1016/j.ijcard.2013.07.260
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9db5fdb6a263d2a41a492b2a4b54a1c0 https://doi.org/10.1016/j.ijcard.2013.07.260 Zobrazit plný text záznamu Full Text from ScienceDirect